-
Rituxan for Hairy Cell Leukemia
Recent literature suggests that a subgroup of Hairy Cell Leukemia(HCL), sometimes called Variant
Read more -
Antibodies to inflixumab
Antibodies to infliximab (ATIs) have been associated with loss of clinical response and lower
Read more -
Afinitor with octreotide for eenuroendocrine cancer – pro
Both Afinitor (everolimus) and octreotide are FDA approved for neuroendocrine cancer. The
Read more -
Rituxan or Rituxan with cladribine for Variant Hairy Cell Leukemia – pro
Recent literature suggests that a subgroup of Hairy Cell Leukemia(NCL), sometimes called Variant
Read more -
Proton Beam Radiotherapy for Craniospinal Radiation – pro
Proton beam therapy is similar to 3-Dimensional and cofnromal readiatherapy but it uses proton
Read more -
What We Offer
Find unique information about modern cancer treatments and emerging technologies here. 'Recent
Read more
DLI for T cell leukemia and lymphoma – pro
Donor lymphocyte infusions are designed to awaken some degree of graft versus host reaction, which contains within it also the graft
-
Ibrutinib for CLL – pro
Ibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor. The effectiveness and safety of ibrutinib
Read more -
Symphony suite of tests for Breast Cancer – pro
Symphony suite of tests includes Mammaprint, BluePrint and TargetPrint. According to the online article
Read more -
Atypical CML – pro
Atypical chronic myelogenous leukemia (aCML) is a leukemic disorder that exhibits both myelodysplastic
Read more -
Olysio and Sovaldi – pro
The literature supports intereferon with the two recently FDA approved oral medications that can be
Read more